Lataa...

Understanding the outcomes measures used in Huntington disease pharmacologicaltrials: A systematic review

BACKGROUND: The identification of the gene mutation causing Huntington disease has raised hopes for new treatments to ease symptoms and slow functional decline. As such, there has been a push towards designing efficient pharmacological trials (i.e., drug trials), especially with regard to selecting...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Carlozzi, Noelle E, Miciura, Angela, Migliore, Nicholas, Dayalu, Praveen
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 2014
Aiheet:
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4217648/
https://ncbi.nlm.nih.gov/pubmed/25300328
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3233/JHD-140115
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!